Managing comorbidities in patients at the end of life
- PMID: 15485977
- PMCID: PMC523125
- DOI: 10.1136/bmj.329.7471.909
Managing comorbidities in patients at the end of life
Abstract
Chronic conditions require careful management in patients who develop a life limiting illness. Doctors need to consider both the physical and psychological effects of treatment
Figures
Comment in
-
Side effects deserve greater emphasis at end of life.BMJ. 2005 Jan 1;330(7481):43. doi: 10.1136/bmj.330.7481.43-a. BMJ. 2005. PMID: 15626812 Free PMC article. No abstract available.
References
-
- Coebergh JW, Janssen-Heijnen ML, Post PN, Razenberg PP. Serious comorbidity among unselected cancer patients newly diagnosed in southeastern part of the Netherlands in 1993-1996. J Clin Epidemiol 1999;52: 1131-6. - PubMed
-
- Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. JAMA 2002;287: 337-44. - PubMed
-
- Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996;14: 447-50. - PubMed
-
- Mannesse CK, Derkx FHM, De Ridder MAJ, Man in't Veld AJ, Van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29: 35-9. - PubMed
-
- Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection. Ann Intern Med 2000;133: 430-4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical